False
November 18, 2025
Our latest news roundup reports on the FDA’s new “plausible mechanism” pathway, Novartis’s phase III malaria trial, a new gene therapy in Europe, and more.
4 min read
November 12, 2025
Our latest news roundup reports on Novartis’ new radioligand facility in California, new tech for boosting AAV yields, and MeiraGTx’s deal with Eli Lilly
4 min read
November 11, 2025
Lyell Immunopharma acquires rights to CAR T cell therapy for solid tumors
2 min read
November 10, 2025
Expanded collaboration between Recipharm Advanced Bio and the UK’s University of Oxford targets vaccine candidates for malaria
4 min read
November 6, 2025
An invitation to our readers to feed back on our content
1 min read
November 5, 2025
Tidmarsh reportedly resigns from FDA and Aurinia Pharmaceuticals files lawsuit
2 min read
October 31, 2025
The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.
3 min read
October 31, 2025
Texas Attorney General is suing Tylenol manufacturers, alleging misleading safety concerns and links with autism.
2 min read
October 30, 2025
October 2025 highlights in the small molecules sector include developments in dermatitis treatment, improvements in epilepsy symptoms, and the effects of amoxicillin availability.
4 min read
October 29, 2025
Day 3 of our special show coverage of CPHI Frankfurt
2 min read
False